PCHM Stock Overview
Provides PharmChek Sweat Patch that is used to detect drugs of abuse. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
PharmChem, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.05 |
| 52 Week High | US$4.00 |
| 52 Week Low | US$2.51 |
| Beta | 0 |
| 1 Month Change | -3.17% |
| 3 Month Change | -15.75% |
| 1 Year Change | 13.81% |
| 3 Year Change | -37.76% |
| 5 Year Change | 38.64% |
| Change since IPO | -67.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCHM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -3.4% | -3.5% |
| 1Y | 13.8% | 9.0% | 22.1% |
Return vs Industry: PCHM exceeded the US Medical Equipment industry which returned 11.2% over the past year.
Return vs Market: PCHM underperformed the US Market which returned 24% over the past year.
Price Volatility
| PCHM volatility | |
|---|---|
| PCHM Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PCHM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PCHM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Thompson Clark | www.pharmchek.com |
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
PharmChem, Inc. Fundamentals Summary
| PCHM fundamental statistics | |
|---|---|
| Market cap | US$14.18m |
| Earnings (TTM) | -US$2.04m |
| Revenue (TTM) | US$25.73m |
0.0x
P/S Ratio0.0x
P/E RatioIs PCHM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCHM income statement (TTM) | |
|---|---|
| Revenue | US$25.73m |
| Cost of Revenue | US$19.98m |
| Gross Profit | US$5.74m |
| Other Expenses | US$7.78m |
| Earnings | -US$2.04m |
Last Reported Earnings
Mar 31, 2004
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PCHM perform over the long term?
See historical performance and comparisonDividends
8.2%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 11:05 |
| End of Day Share Price | 2024/12/09 00:00 |
| Earnings | 2004/03/31 |
| Annual Earnings | 2003/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PharmChem, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|